Suppr超能文献

Tei指数作为评估实验性尿毒症心肌病模型早期预测指标的作用。

The role of Tei index as an early predictor for evaluating experimental uremic cardiomyopathy model.

作者信息

Cheng Shi, Lu Wei, Xu Jiarui, Yu Yong, Fang Yi, Tan Xiao, Chen Ruizhen, Shen Bo, Ding Xiaoqiang, Xie Yeqing

机构信息

Department of Nephrology, Zhongshan Hospital, Fudan University, No.180, Fenglin Road, Xuhui District, Shanghai, 200032, China.

Shanghai Key Laboratory of Kidney Disease and Dialysis, Shanghai, 200032, China.

出版信息

BMC Nephrol. 2025 Jul 1;26(1):327. doi: 10.1186/s12882-025-04203-2.

Abstract

BACKGROUND

Uremic cardiomyopathy (UCM) remains the leading cause of cardiovascular mortality in patients with end-stage renal disease (ESRD). Experimental animal models serve as essential tools for elucidating the potential mechanism underlying UCM. However, experimental UCM models are often challenged by inter-individual variability and inconsistent success rates. Reliable phenotypes are not guaranteed by current animal models of UCM. In this study, Tei index from echocardiography was investigated for its potential value in construction of murine UCM model based on 5/6 nephrectomy (Nx).

METHODS

Comprehensive echocardiographic assessment, measurement of blood pressure and serum creatinine, histological analysis, and quantitative polymerase chain reaction (qPCR) were performed to reveal the relationship between Tei index and construction of UCM model.

RESULTS

The Tei index was significantly elevated in Nx mice despite preserved cardiac function and structural integrity at 8 weeks post-nephrectomy. A longitudinal follow-up to the 12 week revealed that the Nx mice with higher Tei index (Nx HT) presented distinct features of hemodynamic remodeling, left ventricular hypertrophy and diastolic dysfunction. Furthermore, pronounced myocardial hypertrophy and extensive myocardial interstitial fibrosis were confirmed in the Nx HT group.

CONCLUSIONS

This study validates the Tei index as a sensitive and non-invasive parameter for the early evaluation and prediction of UCM murine model induced by 5/6 nephrectomy.

摘要

背景

尿毒症心肌病(UCM)仍然是终末期肾病(ESRD)患者心血管死亡的主要原因。实验动物模型是阐明UCM潜在机制的重要工具。然而,实验性UCM模型常常受到个体间差异和成功率不一致的挑战。目前的UCM动物模型无法保证可靠的表型。在本研究中,基于超声心动图的Tei指数在基于5/6肾切除术(Nx)构建小鼠UCM模型中的潜在价值进行了研究。

方法

进行全面的超声心动图评估、血压和血清肌酐测量、组织学分析以及定量聚合酶链反应(qPCR),以揭示Tei指数与UCM模型构建之间的关系。

结果

尽管肾切除术后8周心脏功能和结构完整性得以保留,但Nx小鼠的Tei指数显著升高。对12周的纵向随访显示,Tei指数较高的Nx小鼠(Nx HT)表现出明显的血流动力学重塑、左心室肥厚和舒张功能障碍特征。此外,Nx HT组证实有明显的心肌肥厚和广泛的心肌间质纤维化。

结论

本研究验证了Tei指数作为5/6肾切除诱导的UCM小鼠模型早期评估和预测的敏感且非侵入性参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/aa2dc3830cb8/12882_2025_4203_Fig1_HTML.jpg

相似文献

1
The role of Tei index as an early predictor for evaluating experimental uremic cardiomyopathy model.
BMC Nephrol. 2025 Jul 1;26(1):327. doi: 10.1186/s12882-025-04203-2.
2
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Systematic review on urine albumin testing for early detection of diabetic complications.
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
10
Sertindole for schizophrenia.
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.

本文引用的文献

1
Roles of AhR/CYP1s signaling pathway mediated ROS production in uremic cardiomyopathy.
Toxicol Lett. 2024 May 15;396:81-93. doi: 10.1016/j.toxlet.2024.04.005. Epub 2024 Apr 24.
2
Echocardiographic manifestations in end-stage renal disease.
Heart Fail Rev. 2024 Mar;29(2):465-478. doi: 10.1007/s10741-023-10376-5. Epub 2023 Dec 10.
4
Myocardial performance index and cardiovascular diseases.
Echocardiography. 2023 Jul;40(7):720-725. doi: 10.1111/echo.15628. Epub 2023 May 29.
5
Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy.
Circ Res. 2023 Apr 14;132(8):1034-1049. doi: 10.1161/CIRCRESAHA.123.321759. Epub 2023 Apr 13.
7
Non-invasive assessment of HFpEF in mouse models: current gaps and future directions.
BMC Med. 2022 Oct 14;20(1):349. doi: 10.1186/s12916-022-02546-3.
8
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease.
Nat Rev Nephrol. 2022 Nov;18(11):696-707. doi: 10.1038/s41581-022-00616-6. Epub 2022 Sep 14.
9
Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease.
Redox Biol. 2022 Oct;56:102459. doi: 10.1016/j.redox.2022.102459. Epub 2022 Aug 30.
10
Cardiac metabolic remodelling in chronic kidney disease.
Nat Rev Nephrol. 2022 Aug;18(8):524-537. doi: 10.1038/s41581-022-00576-x. Epub 2022 May 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验